183 related articles for article (PubMed ID: 31798450)
1. Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam.
Zhou L; Bao J; Ma J
Front Pharmacol; 2019; 10():1342. PubMed ID: 31798450
[No Abstract] [Full Text] [Related]
2. Cefoperazone/sulbactam-induced hemolytic anemia.
Sun XM; Liu LH; Wu Q; Wang HG
J Postgrad Med; 2023; 69(1):46-49. PubMed ID: 34528516
[TBL] [Abstract][Full Text] [Related]
3. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
Baek EJ; Lee S; Kim S; Choi HK; Kim HO
Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy.
Wu Y; Wu Y; Ji Y; Liang J; He Z; Liu Y; Tang L; Guo G
Front Med (Lausanne); 2021; 8():697192. PubMed ID: 34485334
[TBL] [Abstract][Full Text] [Related]
5. Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.
Wang Z; Li Z; Luo S; Yang Z; Xing Y; Pu C; Dong J
J Int Med Res; 2021 Jun; 49(6):3000605211025367. PubMed ID: 34162261
[TBL] [Abstract][Full Text] [Related]
6. A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.
Huang J; Zhu X; Jiang C; Liu Z
Ann Palliat Med; 2020 Nov; 9(6):4377-4383. PubMed ID: 33302688
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
[TBL] [Abstract][Full Text] [Related]
8. Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.
Cai Z; Yang W; He Y; Chen Q; Wang S; Luo X; Wang X
Drug Saf Case Rep; 2016 Dec; 3(1):2. PubMed ID: 27747682
[TBL] [Abstract][Full Text] [Related]
9. Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma.
Lu H; Wang N; Wang P; Zhang H; Zhao R; Liu H; He X; Liu Z; Chang Y; Cao Y; Wang S
Front Med (Lausanne); 2022; 9():917485. PubMed ID: 36091696
[TBL] [Abstract][Full Text] [Related]
10. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
Beck TN; Young NG; Erickson ML; Prats I
BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis.
Shao X; Ren Y; Xie N; Fan K; Sun H; Lu J; Wei J; Tian X
Med Sci Monit; 2023 Jun; 29():e939203. PubMed ID: 37271979
[TBL] [Abstract][Full Text] [Related]
12. Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam.
Qu YJ; Jin SB; Han XC; Zheng LQ
An Bras Dermatol; 2016; 91(6):808-810. PubMed ID: 28099605
[TBL] [Abstract][Full Text] [Related]
13. A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis.
Tsujikawa K; Kuwayama K; Miyaguchi H; Kanamori T; Iwata Y; Inoue H; Kishi T
J Forensic Sci; 2008 Jan; 53(1):226-31. PubMed ID: 18279263
[TBL] [Abstract][Full Text] [Related]
14. Cefoperazone-sulbactam and ornidazole for
Mu Y; Li JJ; Wu X; Zhou XF; Tang L; Zhou Q
World J Clin Cases; 2022 Sep; 10(26):9323-9331. PubMed ID: 36159406
[TBL] [Abstract][Full Text] [Related]
15. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577
[TBL] [Abstract][Full Text] [Related]
16. The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.
Quintanilla-Bordás C; Castro-Izaguirre E; Carcelén-Gadea M; Marín M
Transfusion; 2019 May; 59(5):1648-1650. PubMed ID: 30702749
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
[TBL] [Abstract][Full Text] [Related]
18. Use of cefoperazone/sulbactam in neonates.
Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
[TBL] [Abstract][Full Text] [Related]
19. [Cefoperazone/sulbactam in continuous infusion].
Woźnica R; Ferenc K; Kurec D
Anestezjol Intens Ter; 2010; 42(2):80-4. PubMed ID: 21413432
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
